Moreover, in patients with sporadic late-onset disease, higher levels of the short Aβ38, which arises from more efficient processivity of PS1/PS2–γ-secretase (Fig 1A), are associated with a lower degree of AD-related changes [29]. The gene discussed is PSEN2; the disease is Alzheimer disease.